Tobacco plants transformed into ‘green bioreactors’ to benefit human health

This work is the first of its kind to demonstrate that this functional human protein can be produced in tobacco plant cells, offering the potential to produce pharmaceuticals in a way that is much more affordable than current methods.

Researchers at Western University and Lawson Health Research Institute are using tobacco plants as ‘green bioreactors’ to produce an anti-inflammatory protein with powerful therapeutic potential.

The plants are being used to produce large quantities of a human protein called Interleukin 37, or IL-37. The protein is naturally produced in the human kidney in very small quantities and has powerful anti-inflammatory and immune-suppressing properties, providing potential for treating a number of inflammatory and autoimmune disorders like type 2 diabetes, stroke, dementia and arthritis.

“This protein is a master regulator of inflammation in the body, and has been shown in pre-clinical models to be effective in treating a whole host of diseases,” said Dr. Tony Jevnikar, Professor at Western’s Schulich School of Medicine & Dentistry and Scientist at Lawson. “The human kidney produces IL-37, but not nearly enough to get us out of an inflammation injury.”

And while showing promise in animal models, IL-37’s use clinically has been limited because of the inability to produce it in large quantities at a price that is feasible clinically. Currently, it can be made in very small amounts using the bacteria E. coli, but at a very high cost.

That’s where the tobacco plants come in.

This work is the first of its kind to demonstrate that this functional human protein can be produced in plant cells. “The plants offer the potential to produce pharmaceuticals in a way that is much more affordable than current methods,” said Shengwu Ma, PhD, Adjunct Professor in the Department of Biology at Western and Scientist at Lawson. “Tobacco is high-yield, and we can temporarily transform the plant so that we can begin making the protein of interest within two weeks.”

Dr. Tony Jevnikar and Shengwu Ma, PhD, in the Greenhouse at Western University

The researchers have shown in a recent study published in the journal Plant Cell Reports, that the protein can be extracted and quantified from the plant cells in a way that maintains its function. Now that they’ve shown they can produce the protein in tobacco, it can be translated to other plants, like potatoes.

Dr. Jevnikar is investigating the effect that IL-37 has for preventing organ injury during transplantation. When an organ is removed for transplantation and then transferred to a recipient, inflammation occurs when the blood flow is restored to the organ. He and his team believe IL-37 provides a way to prevent that injury.

“I hope that this work will impact a change in how people view plants and hopefully this approach will be a way to provide treatments to patients that are effective and affordable,” Dr. Jevnikar said.

MEDIA CONTACT: Crystal Mackay, Media Relations Officer, Schulich School of Medicine & Dentistry, Western University, t. 519.661.2111 ext. 80387, c. 519.933.5944, crystal.mackay@schulich.uwo.ca @CrystalMackay

ABOUT WESTERN
Western University delivers an academic experience second to none. Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities. Our research excellence expands knowledge and drives discovery with real-world application. Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.

ABOUT THE SCHULICH SCHOOL OF MEDICINE & DENTISTRY
The Schulich School of Medicine & Dentistry at Western University is one of Canada’s preeminent medical and dental schools. Established in 1881, it was one of the founding schools of Western University and is known for being the birthplace of family medicine in Canada. For more than 130 years, the School has demonstrated a commitment to academic excellence and a passion for scientific discovery.

ABOUT LAWSON HEALTH RESEARCH INSTITUTE

As the research institute of London Health Sciences Centre and St. Joseph’s Health Care London, and working in partnership with Western University, Lawson Health Research Institute is committed to furthering scientific knowledge to advance health care around the world.

Downloadable Media

Images

Drs. Tony Jevnikar and Shengwu Ma
Dr. Tony Jevnikar and Shengwu Ma, PhD, in the Greenhouse at Western University